The 11 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 72.00, with a high estimate of 100.00 and a low estimate of 64.00. The median estimate represents a +56.15% increase from the last price of 46.11.
The current consensus among 11 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.62
Reporting Date Mar 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.